Invasive Malignant Neoplasm — Trials

Invasive Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,820 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 604
Recruiting: 302
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 351–356 of 356 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05022914	PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE(PSICHE)	recruiting	—	180	Azienda Ospedaliero-Universitaria CareggiOTHER	1	Aug 26, 2021	clinicaltrials
NCT02073500	Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies(PSM)	recruiting	—	300	Oslo University HospitalOTHER	1